The Current Status of Neural Grafting in the Treatment of Huntington?s Disease. A Review
Authors:
Open Access
- 1 January 2011
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Integrative Neuroscience
- Vol. 5, 78
Abstract
Huntington's disease (HD) is a devastating, fatal, autosomal dominant condition in which the abnormal gene codes for a mutant form of huntingtin that causes widespread neuronal dysfunction and death. This leads to a clinical presentation, typically in midlife, with a combination of motor, psychiatric, cognitive, metabolic, and sleep abnormalities, for which there are some effective symptomatic therapies that can produce some transient benefits. The disease, though, runs a progressive course over a 20-year period ultimately leading to death, and there are currently no proven disease modifying therapies. However whilst the neuronal dysfunction and loss affects much of the central nervous system, the striatum is affected early on in the disease and is one of the areas most affected by the pathogenic process. As a result the prospect of treating HD using neural transplants of striatal tissue has been explored and to date the clinical data is inconclusive. In this review we discuss the rationale for treating HD using this approach, before discussing the clinical trial data and what we have learnt to date using this therapeutic strategy.Keywords
This publication has 74 references indexed in Scilit:
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisThe Lancet Neurology, 2011
- Neural transplants in patients with Huntington's disease undergo disease-like neuronal degenerationProceedings of the National Academy of Sciences, 2009
- A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesionsActa Neuropathologica, 2008
- Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's diseaseBMC Neuroscience, 2008
- Stem cell transplantation for Huntington's diseaseExperimental Neurology, 2007
- Alloimmunisation to Donor Antigens and Immune Rejection Following Foetal Neural Grafts to the Brain in Patients with Huntington's DiseasePLOS ONE, 2007
- Behavioral recovery after transplantation into a rat model of Huntington's disease: Dependence on anatomical connectivity and extensive postoperative training.Behavioral Neuroscience, 2000
- Striatal Transplantation in a Transgenic Mouse Model of Huntington's DiseaseExperimental Neurology, 1998
- Stereotactic Technique and Pathophysiological Mechanisms of Neurotransplantation in Huntington's ChoreaStereotactic and Functional Neurosurgery, 1992
- A controlled clinical trial of baclofen as protective therapy in early huntington's diseaseAnnals of Neurology, 1989